PuSH - Publication Server of Helmholtz Zentrum München

45 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Leinhäuser, I. ; Atkinson, M.J. & Pellegata, N.S.: The transcription factor Phox2a plays a pro-tumorigenic role in pheochromocytoma. Eur. J. Cancer 50, S160 (2014)
Martin, A. et al.: Cullin-RING ligases inhibition is a potential new therapeutic strategy in soft tissue sarcomas. Eur. J. Cancer 50, S159 (2014)
Michna, A. et al.: Identification of molecular targets and signalling networks that influence hypersensitivity to ionizing radiation. Eur. J. Cancer 50, S134 (2014)
Morscher, S.* et al.: Pharmacokinetic modelling in Dynamic Contrast Enhanced Multispectral Optoacoustic Tomography (DCE-MSOT). Eur. J. Cancer 50, S160-S161 (2014)
Pastula, A.* ; Hauck, S.M. ; Janssen, K.P.* ; Schmid, R.M.* & Quante, M.*: Mesenchymal cells regulate growth of intestinal crypts by a Wnt independent mechanism in 3D culture system. Eur. J. Cancer 50, S63 (2014)
Pellegata, N.S. et al.: p27 is a haploinsufficient tumor suppressor in MENX rats and this associates with the development of invasive medullary thyroid carcinoma. Eur. J. Cancer 50, S57 (2014)
Selmansberger, M. et al.: CLIP2 as radiation biomarker in papillary thyroid carcinoma. Eur. J. Cancer 50, S113 (2014)
Simonavicius, N. et al.: Lymphotoxin signalling alters the vasculature to increase tumour cell metastasis. Eur. J. Cancer 50, S88 (2014)
Weller, P.* et al.: The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer. Eur. J. Cancer 50, 1291-1300 (2014)
Wilke, C. et al.: Comparative global characterisation of microRNA-expression in radiation-associated and sporadic breast carcinomas. Eur. J. Cancer 50, S229 (2014)
Cote, M.L.* et al.: Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. Eur. J. Cancer 48, 1957-1968 (2012)
Frank, B.* et al.: Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis. Eur. J. Cancer 48, 114-120 (2012)
Mutze, K.* et al.: DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Eur. J. Cancer 47, 1817-1825 (2011)
Ebelt, K. et al.: Prostate cancer lesions are surrounded by FOXP3⁺, PD-1⁺ and B7-H1⁺ lymphocyte clusters. Eur. J. Cancer 45, 1664-1672 (2009)
Issels, R.D.: Hyperthermia adds to chemotherapy. Eur. J. Cancer 44, 2546-2554 (2008)
Schaefer, K.L.* et al.: Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur. J. Cancer 44, 699-709 (2008)
Verweij, J.* et al.: Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005. Eur. J. Cancer 43, 974-978 (2007)
Debiec-Rychter, M.* et al.: KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur. J. Cancer 42, 1093-1103 (2006)
Rashid, M.U.* & Wichmann, H.-E.: German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur. J. Cancer 41, 2896-2903 (2005)
Zalcberg, J.R.* et al.: Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose 800 mg after progression on 400 mg. Eur. J. Cancer 41, 1751-1757 (2005)